Icometrix

Belgian company Icometrix has developed what it calls the "icobrain portfolio", which contain a range of products that objectively assess the volume of disease-specific brain structures on MR and CT images. The cloud-based AI solution quantifies white brain matter abnormalities and evaluates structural changes in order to diagnose various neurodegenerative diseases.